Royalty Pharma Plc (RPRX)

Oct 13, 2025

Royalty pharma projects 6-12% growth in 2025 portfolio receipts with $2B share buyback plan - MSN

Oct 13, 2025

Oct 13, 2025

Why retail investors pile into Royalty Pharma plc stockQuarterly Profit Summary & Weekly Top Performers Watchlists - newser.com

Oct 13, 2025

Oct 13, 2025

What’s the recovery path for long term holders of Royalty Pharma plcJuly 2025 Rallies & Real-Time Market Trend Scan - newser.com

Oct 13, 2025

Oct 13, 2025

Royalty Pharma plc (RPRX) Stock Analysis: Unveiling a 23.59% Upside Potential in the Biotech Royalty Space - DirectorsTalk Interviews

Oct 13, 2025

Oct 12, 2025

Is this a good reentry point in Royalty Pharma plcQuarterly Investment Review & AI Forecasted Stock Moves - newser.com

Oct 12, 2025

Oct 12, 2025

Royalty Pharma PLC $RPRX Shares Sold by Board of the Pension Protection Fund - MarketBeat

Oct 12, 2025

Oct 12, 2025

Inspire Investing LLC Buys 22,436 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Oct 12, 2025

Oct 12, 2025

What candlestick patterns are forming on Royalty Pharma plcJuly 2025 Setups & Risk Managed Investment Signals - newser.com

Oct 12, 2025

Oct 11, 2025

KLP Kapitalforvaltning AS Increases Position in Royalty Pharma PLC $RPRX - MarketBeat

Oct 11, 2025

Oct 11, 2025

Belpointe Asset Management LLC Purchases New Position in Royalty Pharma PLC $RPRX - MarketBeat

Oct 11, 2025

Oct 10, 2025

Why Royalty Pharma plc (RPD) stock could rally stronglyJuly 2025 Sector Moves & Risk Controlled Stock Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

Royalty Pharma To Announce Third Quarter 2025 Financial Results On November 5, 2025 - TradingView

Oct 09, 2025

Oct 09, 2025

Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025 - The Manila Times

Oct 09, 2025

Oct 09, 2025

Q3 2025 Results Nov 5: Royalty Pharma to Report Results and Host Call/Webcast at 8:00 a.m. ET - Stock Titan

Oct 09, 2025

Oct 09, 2025

Custom watchlist performance reports with Royalty Pharma plcPortfolio Profit Report & Safe Capital Growth Tips - newser.com

Oct 09, 2025

Oct 09, 2025

Royalty Pharma (NASDAQ:RPRX) Raised to Buy (B-) at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 09, 2025

Is Royalty Pharma plc stock a smart buy before Fed meeting2025 Top Gainers & AI Enhanced Execution Alerts - newser.com

Oct 09, 2025

Oct 08, 2025

Will Royalty Pharma (RPRX) Beat Estimates Again in Its Next Earnings Report? - sharewise.com

Oct 08, 2025

Oct 06, 2025

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises - Yahoo Finance

Oct 06, 2025

Oct 06, 2025

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar - sharewise.com

Oct 06, 2025

Oct 06, 2025

Why Royalty Pharma plc stock is a must watch in 2025Weekly Trading Summary & AI Optimized Trade Strategies - newser.com

Oct 06, 2025

Oct 06, 2025

Understanding Royalty Pharma plc’s price movementMarket Growth Review & Accurate Technical Buy Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

A Look at Royalty Pharma’s (RPRX) Valuation Following Imdelltra Royalty Acquisition and Board Enhancement - Sahm

Oct 05, 2025

Oct 05, 2025

Will Royalty Pharma plc stock see PE expansion2025 Analyst Calls & AI Driven Price Predictions - newser.com

Oct 05, 2025

Oct 04, 2025

Royalty Pharma collaborates with Biogen for R&D funding - MSN

Oct 04, 2025

Oct 04, 2025

Royalty Pharma PLC $RPRX Position Increased by Robeco Institutional Asset Management B.V. - MarketBeat

Oct 04, 2025

Oct 03, 2025

Royalty Pharma PLC (NASDAQ:RPRX) Given Average Rating of "Buy" by Analysts - MarketBeat

Oct 03, 2025

Oct 03, 2025

11% Of This Royalty Pharma Insider's Holdings Were Sold - 富途牛牛

Oct 03, 2025

Oct 03, 2025

Will Royalty Pharma's (RPRX) Governance Shift Sharpen Its Edge in Life Sciences Investment? - simplywall.st

Oct 03, 2025

Oct 02, 2025

The Goldman Sachs Group Initiates Coverage on Royalty Pharma (NASDAQ:RPRX) - MarketBeat

Oct 02, 2025

Oct 01, 2025

The Best Biotech Stocks to Buy - Morningstar

Oct 01, 2025

Sep 30, 2025

Goldman Sachs initiates Royalty Pharma stock with Buy rating, $42 target - Investing.com Nigeria

Sep 30, 2025

Sep 30, 2025

Royalty Pharma : Q3 2025 Pre-Quarterly Results Communication - MarketScreener

Sep 30, 2025

Sep 30, 2025

Goldman Sachs Initiates Coverage of Royalty Pharma (RPRX) with Buy Recommendation - Nasdaq

Sep 30, 2025

Sep 30, 2025

Royalty Pharma plc Stock Analysis and ForecastPrice Action Analysis & High Profit Investment Ideas - earlytimes.in

Sep 30, 2025

Sep 30, 2025

Goldman Sachs Starts Royalty Pharma (RPRX) at Buy, PT $42 - StreetInsider

Sep 30, 2025

Sep 30, 2025

Royalty Pharma appoints Ted Love as lead independent director By Investing.com - Investing.com Nigeria

Sep 30, 2025

Sep 29, 2025

We Think Royalty Pharma (NASDAQ:RPRX) Can Stay On Top Of Its Debt - 富途牛牛

Sep 29, 2025

Sep 29, 2025

Royalty Pharma : Bernstein Healthcare Forum Transcript - MarketScreener

Sep 29, 2025